Allgens Medical Technology CO., LTD. (SHA:688613)

SHA:688613 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-12.66	54.23	95.22	120.78
Depreciation & Amortization	18.35	18.04	18.03	13.17
Other Amortization	6.46	4.87	2.28	1.58
Loss (Gain) From Sale of Assets	-0.64	-	-	-
Asset Writedown & Restructuring Costs	-0.2	-0.08	0.32	0.01
Loss (Gain) From Sale of Investments	-17.92	-18.02	-10.23	-14.92
Provision & Write-off of Bad Debts	9.23	1.42	0.61	0.48
Other Operating Activities	-1.4	1.86	-1.71	1.8
Change in Accounts Receivable	-21.15	-30.39	-12.16	-9.52
Change in Inventory	-22.35	-12.71	0.71	1.83
Change in Accounts Payable	25.79	38.52	11.81	16.22
Operating Cash Flow	-19.6	51.68	102.05	129.76
Operating Cash Flow Growth	-	-49.36%	-21.35%	52.89%
Capital Expenditures	-13.43	-21.9	-45.42	-61.22
Sale of Property, Plant & Equipment	0	0.21	0	-
Cash Acquisitions	-24.62	-	-	-
Investment in Securities	-3.63	-96.57	-152	-168.8
Other Investing Activities	55.89	0.19	0.03	0.53
Investing Cash Flow	14.22	-118.08	-197.39	-229.49
Long-Term Debt Issued	-	25	-	47.6
Long-Term Debt Repaid	-10.69	-40.15	-15.67	-56.75
Net Debt Issued (Repaid)	-10.69	-15.15	-15.67	-9.15
Issuance of Common Stock	22.52	-	-	508.33
Common Dividends Paid	-10.78	-17.06	-40.12	-1.24
Other Financing Activities	-	-	-	-7.73
Financing Cash Flow	1.05	-32.22	-55.79	490.21
Foreign Exchange Rate Adjustments	-0.2	0	-0.3	0
Net Cash Flow	-4.54	-98.62	-151.43	390.49
Free Cash Flow	-33.03	29.78	56.63	68.54
Free Cash Flow Growth	-	-47.42%	-17.38%	140.72%
Free Cash Flow Margin	-16.03%	13.15%	23.09%	29.04%
Free Cash Flow Per Share	-0.23	0.23	0.42	0.57
Cash Income Tax Paid	22.93	16.52	10.57	20.5
Levered Free Cash Flow	-22.86	18.41	5.93	11.95
Unlevered Free Cash Flow	-21.02	20.36	7.09	14.09
Change in Working Capital	-20.84	-10.65	-2.47	6.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.